Association between Follicular Fluid Leptin and Serum Insulin Levels in Nonoverweight Women with Polycystic Ovary Syndrome

Table 1

Anthropometric and metabolic characteristics and hormone levels in the experimental subjects.

	NOW-PCOS	Control-NOW	𝑝 value
Age (years)	32.09±3.60	34.35±3.13	0.04
BMI (Kg/m^2)	22.55±2.61	22.55±2.55	0.99
Insulinemia (𝜇U/mL)	10.30±7.44	9.39±9.27	0.73
HOMA-IR	2.57±2.06	2.37±2.72	0.76
FSH (mlU/mL)	5.71±2.02	6.96±2.34	0.07
LH (mlU/mL)	8.12±4	4.77±1.61	0.001
17𝛽-E2 (basal) (pg/mL)	32.6±13.40	95.56±131.63	0.07
FF-leptin (ng/mL)	7.12±1.12	14.44±4.67	0.037
Serum leptin (ng/mL)	5.31±1.13	11.49±4.21	0.045
FF-visfatin (ng/mL)	4.55±0.59	2.88±0.88	0.075
Serum visfatin (ng/mL)	8.66±0.81	7.24±1.48	0.74

NOW: nonoverweight; control-NOW: controls; BMI: body mass index; E₂: estradiol; FF: follicular fluid; FSH: follicle stimulating hormone; LH: luteinizing hormone. Data are expressed as mean ± SEM. Differences between groups were considered significant for 𝑝≤0.05.